RAS mutations in the development of MM
Disease stage . | RAS mutations (%) . | RAS type (n) . |
|---|---|---|
| MGUS | 1/20 (5) | N-61 (1) |
| MM Total | 18/58 (31) | |
| Stage I | 4/13 (31) | N-61 (1), K-13 (1), K-61 (2) |
| Stage II | 4/11 (36) | N-61 (1), K-12 (1), K-13 (1), K-61 (1) |
| Stage III | 10/34 (29) | N-61 (4), N-13 (1), K-61 (5) |
| ExPCT medullary PC | 0/13 (0) | |
| Extramedullary PC | 3/6 (50) | K-61 (2), N-61 (1) |
Disease stage . | RAS mutations (%) . | RAS type (n) . |
|---|---|---|
| MGUS | 1/20 (5) | N-61 (1) |
| MM Total | 18/58 (31) | |
| Stage I | 4/13 (31) | N-61 (1), K-13 (1), K-61 (2) |
| Stage II | 4/11 (36) | N-61 (1), K-12 (1), K-13 (1), K-61 (1) |
| Stage III | 10/34 (29) | N-61 (4), N-13 (1), K-61 (5) |
| ExPCT medullary PC | 0/13 (0) | |
| Extramedullary PC | 3/6 (50) | K-61 (2), N-61 (1) |